Tag archive for ‘Cubist Pharmaceuticals’
Trius: Will there be a Higher Bidder and what is the CVR Worth? (TSRX; $14.10)
What is the CVR Worth? I wanted to address some additional points in regard to the proposed acquisition of Trius (TSRX) by Cubist (CBST). In my earlier note of July 31, I had not yet analyzed the terms of the CVR which are that Trius shareholders will receive $1.00 for each share that they tender […]
Trius Therapeutics to be Acquired by Cubist (TSRX: $13.66)
Implications for Trius Shareholders Cubist Pharmaceuticals (CBST) and Trius Therapeutics, Inc. (TSRX) announced that they have signed a definitive agreement under which Cubist will acquire all outstanding shares of Trius for $13.50 per share in cash. In addition, Trius shareholders will receive a Contingent Value Right that entitles Trius shareholders to receive up to $2.00 […]